Toku

Toku Inc. is a cutting-edge technology company specializing in the development of non-invasive, AI-driven diagnostic and screening tools that use retinal imaging to measure cardiovascular and other health risk factors. The company's flagship product, the BioAge Test, utilizes advanced imaging technology to analyze various biomarkers in the body to accurately measure an individual's biological age. The test is highly accurate and provides a detailed report on a person’s overall health and potential health risks, including cardiovascular diseases and stroke. Toku is committed to making its technology widely accessible, and the BioAge Test will soon be available through its key global partnerships.